Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)

Y Shen, S Huang, J Kang, J Lin, K Lai… - … journal of chronic …, 2018 - Taylor & Francis
Airway mucus hypersecretion is one of the most important characteristics of chronic airway
inflammatory diseases. Evaluating and managing airway mucus hypersecretion is of great …

[HTML][HTML] Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review

A Machado, M Barusso, J De Brandt, K Quadflieg… - Pulmonology, 2023 - Elsevier
This scoping review summarized the evidence regarding the impact of acute exacerbations
of COPD (AECOPD) on patients' health status beyond pulmonary function. PubMed …

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active …

PMA Calverley, AR Anzueto, K Carter… - The Lancet …, 2018 - thelancet.com
Background Combinations of long-acting bronchodilators are recommended to reduce the
rate of chronic obstructive pulmonary disease (COPD) exacerbations. It is unclear whether …

[HTML][HTML] Mucus structure, viscoelastic properties, and composition in chronic respiratory diseases

M Abrami, A Biasin, F Tescione, D Tierno… - International Journal of …, 2024 - mdpi.com
The respiratory mucus, a viscoelastic gel, effectuates a primary line of the airway defense
when operated by the mucociliary clearance. In chronic respiratory diseases (CRDs), such …

Increased small intestinal permeability during severe acute exacerbations of COPD

RTM Sprooten, K Lenaerts, DCW Braeken… - Respiration, 2018 - karger.com
Background: Disturbances of intestinal integrity, manifested by increased gastro-intestinal
(GI) permeability, have been found in chronic obstructive pulmonary disease (COPD) …

A long-term study of adverse outcomes associated with oral corticosteroid use in COPD

G Tse, B Emmanuel, C Ariti, M Bafadhel… - … journal of chronic …, 2023 - Taylor & Francis
Background Oral corticosteroids (OCS) are often prescribed for chronic obstructive
pulmonary disease (COPD) exacerbations. Methods This observational, individually …

[HTML][HTML] Immunostimulants in respiratory diseases: focus on Pidotimod

F Puggioni, M Alves-Correia, MF Mohamed… - Multidisciplinary …, 2019 - Springer
Usefulness of Pidotimod and its role as immunostimulant, has been discussed, we know, for
several decades. Nevertheless, there is still much to know. Understanding its mechanisms …

Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio

J Cardoso, R Coelho, C Rocha, C Coelho… - … Journal of Chronic …, 2018 - Taylor & Francis
Background Severe exacerbations and mortality are major outcomes in COPD, and risk
factors for these events are actively searched for. Several predictors of mortality have been …

Physical frailty related to cognitive impairment and COPD exacerbation: a cross-sectional study

CL Tsai, WP Chang, YK Lin, SC Ho, YH Lin - Respiratory Medicine, 2023 - Elsevier
Physical frailty related to cognitive impairment and COPD exacerbation: A cross-sectional
study - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books …

A systematic review on lagged associations in climate–health studies

P Wang, X Zhang, M Hashizume… - International Journal …, 2021 - academic.oup.com
Background Lagged associations in climate–health studies have already been ubiquitously
acknowledged in recent years. Despite extensive time-series models having proposed …